Cargando…
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations
SIMPLE SUMMARY: Cellular proliferation is a central determinant of breast cancer recurrence risk and response to chemotherapy. The discovery of the Ki-67 antibody by Dr. Johannes Gerdes in 1983, with the observation that Ki-67 immunohistochemical expression was only present in proliferating cells, o...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913317/ https://www.ncbi.nlm.nih.gov/pubmed/36765765 http://dx.doi.org/10.3390/cancers15030808 |